| | | NEW YORK (Reuters) - Standard & Poor's on Monday removed the near-term threat of another credit rating downgrade for the United States by revising its outlook to stable from negative, citing an improved economic and fiscal outlook. | | | | | | NEW YORK (Reuters) - Stocks were nearly flat as worries about when or if the Federal Reserve might reduce its stimulus efforts offset a credit outlook upgrade for the United States. | | | | | | | SAN FRANCISCO (Reuters) - Apple Inc on Monday unveiled a music streaming service that is a key part of overhauled mobile software that the company called the most revolutionary re-design of its operating system since the iPhone was introduced in 2007. | | | | | | | BRUSSELS (Reuters) - Delta Air Lines is expected to secure unconditional European regulatory approval to buy a 49 percent stake in Virgin Atlantic, allowing it to compete better with rivals in the lucrative transatlantic market. | | | | | (Reuters) - A former Bristol-Myers Squibb Co finance executive on Monday pleaded guilty to an insider trading charge, admitting to buying stock options in a biotechnology company that the drugmaker was preparing to buy. | | | | | DETROIT (Reuters) - Dutch sports car maker Spyker NV's $3 billion lawsuit accusing General Motors Co of trying to bankrupt Swedish automaker Saab was dismissed by a U.S. federal judge on Monday who said the U.S. automaker had the right to block the sale of a company using its technology. | | | | | DETROIT (Reuters) - General Motors Co said on Monday it is switching its head of North American manufacturing to a new position now that the U.S. automaker has begun building new versions of its highly profitable full-size pickup trucks. | | | | | (Reuters) - Monsanto Co. on Monday won another round in a legal battle with U.S. organic growers as an appeals court threw out the growers' efforts to stop the company from suing farmers if traces of its patented biotech genes are found in crops. | | | | PARIS (Reuters) - The first delivery of the Airbus A400M, Europe's new military airlifter, could slip beyond its second-quarter target date and take place in July, industry sources said. | | | | NEW YORK (Reuters) - Irish drug firm Elan Corp Plc voluntarily dismissed its U.S. lawsuit against Royalty Pharma , the U.S. investment firm which increased its offer to take over Elan last week, a court filing showed on Monday. | | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | | | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment